These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 25970456)

  • 1. Screening: Early alert.
    Willyard C
    Nature; 2015 May; 521(7551):S4-5. PubMed ID: 25970456
    [No Abstract]   [Full Text] [Related]  

  • 2. KRAS mutations and M2PK upregulation in stool samples from individuals with positive fecal occult blood tests screened for colorectal cancer.
    Battaglia P; Baritono E; Remo A; Vendraminelli R; Conti A
    Tumori; 2014; 100(2):122-7. PubMed ID: 24852854
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multitarget stool DNA testing for colorectal-cancer screening.
    Imperiale TF; Ransohoff DF; Itzkowitz SH; Levin TR; Lavin P; Lidgard GP; Ahlquist DA; Berger BM
    N Engl J Med; 2014 Apr; 370(14):1287-97. PubMed ID: 24645800
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Colonoscopy and Sigmoidoscopy Use among the Average-Risk Population for Colorectal Cancer: A Systematic Review and Trend Analysis.
    Cardoso R; Niedermaier T; Chen C; Hoffmeister M; Brenner H
    Cancer Prev Res (Phila); 2019 Sep; 12(9):617-630. PubMed ID: 31289028
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The subjective decision of cessation of colorectal cancer screening.
    Daniel CL; Keyes D; Gilreath K
    Lancet Gastroenterol Hepatol; 2017 Oct; 2(10):698-699. PubMed ID: 28895544
    [No Abstract]   [Full Text] [Related]  

  • 6. Impact of screening colonoscopy on outcomes in colorectal cancer.
    Matsuda T; Ono A; Kakugawa Y; Matsumoto M; Saito Y
    Jpn J Clin Oncol; 2015 Oct; 45(10):900-5. PubMed ID: 26254299
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Colorectal cancer screening among individuals with and without a family history.
    Thrasher JF; Cummings KM; Michalek AM; Mahoney MC; Moysich KB; Pillittere DM
    J Public Health Manag Pract; 2002 Mar; 8(2):1-9. PubMed ID: 11889847
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circulating free DNA in a screening program for early colorectal cancer detection.
    Perrone F; Lampis A; Bertan C; Verderio P; Ciniselli CM; Pizzamiglio S; Frattini M; Nucifora M; Molinari F; Gallino G; Gariboldi M; Meroni E; Leo E; Pierotti MA; Pilotti S
    Tumori; 2014; 100(2):115-21. PubMed ID: 24852853
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Colorectal cancer screening reduces incidence, mortality and morbidity.
    Jideh B; Bourke MJ
    Med J Aust; 2018 Jun; 208(11):483-484. PubMed ID: 29902408
    [No Abstract]   [Full Text] [Related]  

  • 10. Colorectal cancer screening in Europe: compliance and the choice of test.
    Riemann JF
    Endoscopy; 2010 Jul; 42(7):576-7. PubMed ID: 20593335
    [No Abstract]   [Full Text] [Related]  

  • 11. Cost-effectiveness of colonoscopy in screening for colorectal cancer.
    Sonnenberg A; Delcò F; Inadomi JM
    Ann Intern Med; 2000 Oct; 133(8):573-84. PubMed ID: 11033584
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Screening for colorectal cancer in Italy, 2010 survey].
    Zorzi M; Fedato C; Grazzini G; Sassoli de' Bianchi P; Naldoni C; Pendenza M; Sassatelli R; Senore C; Visioli CB; Zappa M
    Epidemiol Prev; 2012; 36(6 Suppl 1):55-77. PubMed ID: 23293271
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Flexible sigmoidoscopy following a positive faecal occult blood test within a bowel screening programme may reduce the detection of neoplasia.
    Mansouri D; McMillan DC; Roxburgh CS; Moug SJ; Crighton EM; Horgan PG
    Colorectal Dis; 2013 Nov; 15(11):1375-81. PubMed ID: 23927751
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adherence to Screening Colonoscopy: Can We Get Our Recommendations to Stick?
    Rogers MC; Keswani RN
    Dig Dis Sci; 2015 Oct; 60(10):2855-6. PubMed ID: 26088369
    [No Abstract]   [Full Text] [Related]  

  • 15. How to Ensure Patient Adherence to Colorectal Cancer Screening and Surveillance in Your Practice.
    Hassan C; Kaminski MF; Repici A
    Gastroenterology; 2018 Aug; 155(2):252-257. PubMed ID: 29964039
    [No Abstract]   [Full Text] [Related]  

  • 16. Recommendations raise workload issues for colon cancer screening.
    Twombly R
    J Natl Cancer Inst; 2004 Mar; 96(5):348-50. PubMed ID: 14996852
    [No Abstract]   [Full Text] [Related]  

  • 17. Colorectal cancer screening.
    Steele RJ
    Br J Surg; 2014 Oct; 101(11):1338-40. PubMed ID: 25088598
    [No Abstract]   [Full Text] [Related]  

  • 18. 2017 Emily Couric Memorial Lecture: Colorectal Cancer: Polyps, Prevention, and Progress.
    Pochapin MB
    Am J Gastroenterol; 2018 Dec; 113(12):1772-1777. PubMed ID: 29997398
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Faecal Occult Blood Point-of-Care Tests.
    Kościelniak-Merak B; Radosavljević B; Zając A; Tomasik PJ
    J Gastrointest Cancer; 2018 Dec; 49(4):402-405. PubMed ID: 30232694
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rolling-out Screening Volume Affecting Compliance Rate and Waiting Time of FIT-based Colonoscopy.
    Jen HH; Hsu CY; Chen SL; Yen AM; Chiu SY; Fann JC; Lee YC; Wu MS; Hsu WF; Peng SM; Chen HH; Chiu HM
    J Clin Gastroenterol; 2018 Oct; 52(9):821-827. PubMed ID: 29095416
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.